PetMed Express

Piper Jaffray is out with its report today on PetMed Express (NASDAQ: PETS), reiterating Underperform. In a note to clients, Piper Jaffray writes, "We reiterate our Underperform rating on PETS as Wag.com, a new online retailer of pet supplies, launched yesterday. Wag.com is owned by Quidsi, which...

According to Wedbush, PetMed Express' (NASDAQ: PETS) target is lowered to $13. Wedbush reported that recent channel checks indicate an ongoing high level of competition (particularly pricing on non-prescription flea and tick products), which may present continued challenges for PETS. “Maintaining...

Piper Jaffray is reiterating its Underweight rating on PetMed Express, Inc. (NASDAQ: PETS) “as we believe heightened competition is continuing to pressure both volumes and pricing on pet medications.” “Recent analysis of traffic to PETS web sites confirms this, in our opinion, as October and...

Piper Jaffray has published a research report on PetMed Express (NASDAQ: PETS) despite the fact that operating challenges are currently troubling the company. In the report, Piper Jaffray writes "We remain cautious on shares of PETS ahead of the company's FQ2 results, expected to be released before...

William Blair & Company analysts Daniel Hofkin and Mark Miller reiterated their Outperform rating for shares of PetMed Express, Inc. (Nasdaq: PETS). The analysts said that a recent decision by BAYER AKTIENGES (OTC: BAYRY.PK) to broaden its distribution to over the counter sales would produce...